##### Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 FORM 10-Q
 (Mark One)
 þ
    
    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 For the quarterly period ended June 30, 2009
 o
    
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 For the transition period from  to
 Commission File Number: 0-17995
 ZIX CORPORATION
 (Exact Name of Registrant as Specified in its Charter)
 Texas
(State of Incorporation)
    
    75-2216818
(I.R.S. Employer Identification Number)
 2711 North Haskell Avenue
Suite 2200, LB 36
Dallas, Texas 75204-2960
(Address of Principal Executive Offices)
 (214) 370-2000
(Registrants Telephone Number, Including Area Code)
 Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the Registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o
 Indicate by check mark whether the registrant has submitted electronically and posted on its
corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period
that the registrant was required to submit and post such files). Yes o No o
 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated
filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
(Check one):
 Large accelerated filer oAccelerated filer þNon-accelerated filer o(Do not check if a smaller reporting company)Smaller reporting company o Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act). Yes o No þ
 Indicate the number of shares outstanding of each of the issuers classes of common stock, as of
the latest practicable date.
 Class
    

Outstanding at August 3, 2009Common Stock, par value $0.01 per share
    
    63,319,482




---



##### 



INDEX
 PageNumberPART I  FINANCIAL INFORMATIONItem 1. Financial Statements (Unaudited)Condensed Consolidated Balance Sheets at June 30, 2009 and December 31, 2008
    
    3Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2009 and 2008
    
    4Condensed Consolidated Statement of Stockholders Deficit for the six months ended June 30, 2009
    
    5Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2009 and 2008
    
    6Notes to Condensed Consolidated Financial Statements
    
    7Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
    
    11Item 3. Quantitative and Qualitative Disclosures About Market Risk
    
    19Item 4. Controls and Procedures
    
    19PART II  OTHER INFORMATIONItem 1. Legal Proceedings
    
    19Item 1A. Risk Factors
    
    19Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
    
    20Item 3. Defaults Upon Senior Securities
    
    21Item 4. Submission of Matters to a Vote of Security Holders
    
    21Item 5. Other Information
    
    21Item 6. Exhibits
    
    22EX-31.1EX-31.2EX-32.1
  2




---



##### Table of Contents



ZIX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
 June 30,
    
    
    December 31,2009
    
    
    2008(unaudited)ASSETSCurrent assets:Cash and cash equivalents
    
    $
    12,494,000
    
    
    $
    13,245,000Marketable securities
    
    
    25,000
    
    
    
    Receivables, net
    
    
    628,000
    
    
    
    476,000Prepaid and other current assets
    
    
    913,000
    
    
    
    1,145,000Total current assets
    
    
    14,060,000
    
    
    
    14,866,000Restricted cash
    
    
    
    
    
    
    28,000Property and equipment, net
    
    
    2,254,000
    
    
    
    2,236,000Goodwill
    
    
    2,161,000
    
    
    
    2,161,000Other assets
    
    
    309,000
    
    
    
    66,000Total assets
    
    $
    18,784,000
    
    
    $
    19,357,000LIABILITIES AND STOCKHOLDERS DEFICITCurrent liabilities:Accounts payable
    
    $
    1,093,000
    
    
    $
    512,000Accrued expenses
    
    
    3,029,000
    
    
    
    2,404,000Deferred revenue
    
    
    14,537,000
    
    
    
    14,960,000License subscription note payable
    
    
    121,000
    
    
    
    Total current liabilities
    
    
    18,780,000
    
    
    
    17,876,000Long-term liabilities:Deferred revenue
    
    
    2,888,000
    
    
    
    2,484,000License subscription note payable
    
    
    250,000
    
    
    
    Deferred rent
    
    
    267,000
    
    
    
    300,000Total long-term liabilities
    
    
    3,405,000
    
    
    
    2,784,000Total liabilities
    
    
    22,185,000
    
    
    
    20,660,000Commitments and contingencies (see Note 9)Stockholders deficit:Preferred stock, $1 par value, 10,000,000 shares authorized; none issued and outstanding
    
    
    
    
    
    
    Common stock, $0.01 par value, 175,000,000 shares authorized; 65,646,663 issued and
63,319,482 outstanding in 2009 and 2008
    
    
    656,000
    
    
    
    656,000Additional paid-in capital
    
    
    334,977,000
    
    
    
    333,608,000Treasury stock, at cost; 2,327,181 common shares in 2009 and 2008
    
    
    (11,507,000
    )
    
    
    (11,507,000
    )Accumulated deficit
    
    
    (327,527,000
    )
    
    
    (324,060,000
    )Total stockholders deficit
    
    
    (3,401,000
    )
    
    
    (1,303,000
    )Total liabilities and stockholders deficit
    
    $
    18,784,000
    
    
    $
    19,357,000
  3




---



##### Table of Contents



ZIX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 Three Months Ended June 30,
    
    
    Six Months Ended June 30,2009
    
    
    2008
    
    
    2009
    
    
    2008Revenues
    
    $
    7,371,000
    
    
    $
    6,958,000
    
    
    $
    14,627,000
    
    
    $
    14,157,000Cost of revenues
    
    
    2,368,000
    
    
    
    2,542,000
    
    
    
    4,839,000
    
    
    
    5,122,000Gross profit
    
    
    5,003,000
    
    
    
    4,416,000
    
    
    
    9,788,000
    
    
    
    9,035,000Operating expenses:Research and development
    
    
    1,747,000
    
    
    
    1,381,000
    
    
    
    3,478,000
    
    
    
    2,926,000Selling, general and administrative
    
    
    5,228,000
    
    
    
    4,607,000
    
    
    
    9,872,000
    
    
    
    9,424,000Total operating expenses
    
    
    6,975,000
    
    
    
    5,988,000
    
    
    
    13,350,000
    
    
    
    12,350,000Operating loss
    
    
    (1,972,000
    )
    
    
    (1,572,000
    )
    
    
    (3,562,000
    )
    
    
    (3,315,000
    )Other income, net
    
    
    73,000
    
    
    
    222,000
    
    
    
    141,000
    
    
    
    338,000Loss before income taxes
    
    
    (1,899,000
    )
    
    
    (1,350,000
    )
    
    
    (3,421,000
    )
    
    
    (2,977,000
    )Provision for income taxes
    
    
    (26,000
    )
    
    
    
    
    
    
    (46,000
    )
    
    
    (77,000
    )Net loss
    
    $
    (1,925,000
    )
    
    $
    (1,350,000
    )
    
    $
    (3,467,000
    )
    
    $
    (3,054,000
    )Basic and diluted loss per common share
    
    $
    (0.03
    )
    
    $
    (0.02
    )
    
    $
    (0.05
    )
    
    $
    (0.05
    )Basic and diluted weighted average
common shares outstanding
    
    
    63,319,482
    
    
    
    62,903,431
    
    
    
    63,319,482
    
    
    
    62,803,638
  4




---



##### Table of Contents



ZIX CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS DEFICIT
 Stockholders DeficitAdditional
    
    
    
    
    
    
    
    
    
    
    TotalCommon Stock
    
    
    Paid-In
    
    
    Treasury
    
    
    Accumulated
    
    
    StockholdersShares
    
    
    Amount
    
    
    Capital
    
    
    Stock
    
    
    Deficit
    
    
    DeficitBalance, December 31, 2008
    
    
    65,646,663
    
    
    $
    656,000
    
    
    $
    333,608,000
    
    
    $
    (11,507,000
    )
    
    $
    (324,060,000
    )
    
    $
    (1,303,000
    )Employee stock-based
compensation costs
    
    
    
    
    
    
    
    
    
    
    1,353,000
    
    
    
    
    
    
    
    
    
    
    
    1,353,000Non-employee
stock-based
compensation costs
    
    
    
    
    
    
    
    
    
    
    16,000
    
    
    
    
    
    
    
    
    
    
    
    16,000Net loss
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (3,467,000
    )
    
    
    (3,467,000
    )Balance, June 30, 2009
    
    
    65,646,663
    
    
    $
    656,000
    
    
    $
    334,977,000
    
    
    $
    (11,507,000
    )
    
    $
    (327,527,000
    )
    
    $
    (3,401,000
    )
  5




---



##### Table of Contents



ZIX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 Six Months Ended June 30,2009
    
    
    2008Operating activities:Net loss
    
    $
    (3,467,000
    )
    
    $
    (3,054,000
    )Non-cash items in net loss:Depreciation and amortization
    
    
    648,000
    
    
    
    649,000Employee stock-based compensation costs
    
    
    1,353,000
    
    
    
    1,265,000Non-employee stock-based compensation costs
    
    
    16,000
    
    
    
    Common stock issued to employees as compensation in lieu of cash
    
    
    
    
    
    
    576,000Changes in deferred taxes
    
    
    7,000
    
    
    
    27,000Changes in operating assets and liabilities:Receivables
    
    
    (152,000
    )
    
    
    422,000Prepaid and other current assets
    
    
    374,000
    
    
    
    220,000Accounts payable
    
    
    409,000
    
    
    
    90,000Deferred revenue
    
    
    (19,000
    )
    
    
    819,000Accrued and other liabilities
    
    
    592,000
    
    
    
    129,000Net cash (used in) provided by operating activities
    
    
    (239,000
    )
    
    
    1,143,000Investing activities:Purchases of property and equipment
    
    
    (515,000
    )
    
    
    (544,000
    )Restricted cash and marketable securities, net
    
    
    3,000
    
    
    
    1,734,000Net cash (used in) provided by investing activities
    
    
    (512,000
    )
    
    
    1,190,000Financing activities:Proceeds from exercise of stock options
    
    
    
    
    
    
    150,000Net cash provided by financing activities
    
    
    
    
    
    
    150,000(Decrease) increase in cash and cash equivalents
    
    
    (751,000
    )
    
    
    2,483,000Cash and cash equivalents, beginning of period
    
    
    13,245,000
    
    
    
    10,524,000Cash and cash equivalents, end of period
    
    $
    12,494,000
    
    
    $
    13,007,000
  6




---



##### Table of Contents



ZIX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 1. Basis of Presentation
  2. Recent Accounting Standards and Pronouncements
 Interim Disclosures about Fair Value of Financial
Instruments
 Subsequent Events.
 The FASB Accounting Standards Codification and the
Hierarchy of Generally Accepted Accounting Principles.
 Effective Date of FASB
Statement No. 157
 Business Combinations
 Non-controlling Interests in Consolidated
Financial Statements  an amendment of ARB No. 51
 Determination of the Useful
Life of Intangible Assets Goodwill and Other Intangible
 7




---



##### Table of Contents



Asset.
 3. Segment Information
    Three Months Ended June 30, 2009
    
    
    Three Months Ended June 30, 2008Email
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    EmailEncryption
    
    
    e-Prescribing
    
    
    Corporate
    
    
    Total
    
    
    Encryption
    
    
    e-Prescribing
    
    
    Corporate
    
    
    TotalRevenues
    
    $
    6,379,000
    
    
    $
    992,000
    
    
    $
    
    
    
    $
    7,371,000
    
    
    $
    5,667,000
    
    
    $
    1,291,000
    
    
    $
    
    
    
    $
    6,958,000Cost of revenues
    
    
    1,088,000
    
    
    
    1,280,000
    
    
    
    
    
    
    
    2,368,000
    
    
    
    1,059,000
    
    
    
    1,483,000
    
    
    
    
    
    
    
    2,542,000Gross profit
    
    
    5,291,000
    
    
    
    (288,000
    )
    
    
    
    
    
    
    5,003,000
    
    
    
    4,608,000
    
    
    
    (192,000
    )
    
    
    
    
    
    
    4,416,000Direct expenses
    
    
    2,979,000
    
    
    
    1,749,000
    
    
    
    
    
    
    
    4,728,000
    
    
    
    2,756,000
    
    
    
    1,717,000
    
    
    
    
    
    
    
    4,473,000Segment
contribution (loss)
    
    
    2,312,000
    
    
    
    (2,037,000
    )
    
    
    
    
    
    
    275,000
    
    
    
    1,852,000
    
    
    
    (1,909,000
    )
    
    
    
    
    
    
    (57,000
    )Unallocated
(expense) / Income:Selling, general
and administrative
    
    
    
    
    
    
    
    
    
    
    (2,247,000
    )
    
    
    (2,247,000
    )
    
    
    
    
    
    
    
    
    
    
    (1,515,000
    )
    
    
    (1,515,000
    )Investment and
other income
    
    
    
    
    
    
    
    
    
    
    79,000
    
    
    
    79,000
    
    
    
    
    
    
    
    
    
    
    
    222,000
    
    
    
    222,000Interest expense
    
    
    
    
    
    
    
    
    
    
    (6,000
    )
    
    
    (6,000
    )
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    Total
    
    
    
    
    
    
    
    
    
    
    (2,174,000
    )
    
    
    (2,174,000
    )
    
    
    
    
    
    
    
    
    
    
    (1,293,000
    )
    
    
    (1,293,000
    )Income (loss)
before provision
for income taxes
    
    $
    2,312,000
    
    
    $
    (2,037,000
    )
    
    $
    (2,174,000
    )
    
    $
    (1,899,000
    )
    
    $
    1,852,000
    
    
    $
    (1,909,000
    )
    
    $
    (1,293,000
    )
    
    $
    (1,350,000
    )Depreciation expense
    
    $
    193,000
    
    
    $
    92,000
    
    
    $
    44,000
    
    
    $
    329,000
    
    
    $
    182,000
    
    
    $
    96,000
    
    
    $
    43,000
    
    
    $
    321,000
 Six Months Ended June 30, 2009
    
    
    Six Months Ended June 30, 2008Email
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    EmailEncryption
    
    
    e-Prescribing
    
    
    Corporate
    
    
    Total
    
    
    Encryption
    
    
    e-Prescribing
    
    
    Corporate
    
    
    TotalRevenues
    
    $
    12,621,000
    
    
    $
    2,006,000
    
    
    $
    
    
    
    $
    14,627,000
    
    
    $
    10,956,000
    
    
    $
    3,201,000
    
    
    $
    
    
    
    $
    14,157,000Cost of revenues
    
    
    2,101,000
    
    
    
    2,738,000
    
    
    
    
    
    
    
    4,839,000
    
    
    
    2,109,000
    
    
    
    3,013,000
    
    
    
    
    
    
    
    5,122,000Gross profit
    
    
    10,520,000
    
    
    
    (732,000
    )
    
    
    
    
    
    
    9,788,000
    
    
    
    8,847,000
    
    
    
    188,000
    
    
    
    
    
    
    
    9,035,000Direct expenses
    
    
    5,735,000
    
    
    
    3,594,000
    
    
    
    
    
    
    
    9,329,000
    
    
    
    5,623,000
    
    
    
    3,552,000
    
    
    
    
    
    
    
    9,175,000Segment
contribution (loss)
    
    
    4,785,000
    
    
    
    (4,326,000
    )
    
    
    
    
    
    
    459,000
    
    
    
    3,224,000
    
    
    
    (3,364,000
    )
    
    
    
    
    
    
    (140,000
    )Unallocated
(expense) / Income:Selling, general
and administrative
    
    
    
    
    
    
    
    
    
    
    (4,021,000
    )
    
    
    (4,021,000
    )
    
    
    
    
    
    
    
    
    
    
    (3,175,000
    )
    
    
    (3,175,000
    )Investment and
other income
    
    
    
    
    
    
    
    
    
    
    147,000
    
    
    
    147,000
    
    
    
    
    
    
    
    
    
    
    
    338,000
    
    
    
    338,000Interest expense
    
    
    
    
    
    
    
    
    
    
    (6,000
    )
    
    
    (6,000
    )
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    Total
    
    
    
    
    
    
    
    
    
    
    (3,880,000
    )
    
    
    (3,880,000
    )
    
    
    
    
    
    
    
    
    
    
    (2,837,000
    )
    
    
    (2,837,000
    )Income (loss)
before provision
for income taxes
    
    $
    4,785,000
    
    
    $
    (4,326,000
    )
    
    $
    (3,880,000
    )
    
    $
    (3,421,000
    )
    
    $
    3,224,000
    
    
    $
    (3,364,000
    )
    
    $
    (2,837,000
    )
    
    $
    (2,977,000
    )Depreciation expense
    
    $
    385,000
    
    
    $
    179,000
    
    
    $
    84,000
    
    
    $
    648,000
    
    
    $
    370,000
    
    
    $
    193,000
    
    
    $
    86,000
    
    
    $
    649,000
 8




---



##### Table of Contents



June 30, 2009
    
    
    December 31, 2008Total assets:Email Encryption
    
    $
    3,662,000
    
    
    $
    3,335,000e-Prescribing
    
    
    563,000
    
    
    
    664,000Corporate
    
    
    14,559,000
    
    
    
    15,358,000Total assets
    
    $
    18,784,000
    
    
    $
    19,357,000
 4. Stock Options and Stock-based Employee Compensation
  Three Months
    
    
    Six MonthsEnded June 30,
    
    
    Ended June 30,2009
    
    
    2009Cost of revenues
    
    $
    59,000
    
    
    $
    185,000Research and development
    
    
    49,000
    
    
    
    150,000Selling, general and administrative
    
    
    415,000
    
    
    
    1,018,000Stock-based compensation expense
    
    $
    523,000
    
    
    $
    1,353,000
  Stock Option Activity
  Weighted AverageWeighted
    
    
    Remaining
    
    
    AggregateAverage
    
    
    Contractual Term
    
    
    IntrinsicShares
    
    
    Exercise Price
    
    
    (Yrs)
    
    
    ValueOutstanding at March 31, 2009
    
    
    9,687,604
    
    
    $
    4.47Granted at market price
    
    
    3,000
    
    
    $
    1.22Cancelled or expired
    
    
    (29,278
    )
    
    $
    3.04Exercised
    
    
    
    
    
    $
    Outstanding at June 30, 2009
    
    
    9,661,326
    
    
    $
    4.48
    
    
    
    6.23
    
    
    $
    204,000Options exercisable at June 30, 2009
    
    
    7,997,462
    
    
    $
    4.79
    
    
    
    5.74
    
    
    $
    66,000
 9




---



##### Table of Contents



5. Supplemental Cash Flow Information
  Six Months Ended June 30,2009
    
    2008Cash income tax payments
    
    $
    142,000
    
    
    $
    84,000Non-cash investing and financing activities:Assets sold to customers as part of their subscription service
    
    $
    2,000
    
    
    $
    16,000Stock issued in lieu of accrued expenses
    
    $
    
    
    
    $
    422,000Payables related to purchases of fixed assets
    
    $
    153,000
    
    
    $
    Issuance of license subscription note payable
    
    $
    390,000
    
    
    $
    Amounts reclassified from Notes payable to Accounts payable
    
    $
    19,000
    
    
    $
    
 6. Fair Value Measurements
  7. Receivables, net
 June 30,
    
    
    December 31,2009
    
    
    2008Gross accounts receivable
    
    $
    5,219,000
    
    
    $
    3,682,000Allowance for returns and doubtful accounts
    
    
    (43,000
    )
    
    
    (37,000
    )Unpaid portion of deferred revenue
    
    
    (4,548,000
    )
    
    
    (3,169,000
    )Receivables, net
    
    $
    628,000
    
    
    $
    476,000
   8. Earnings Per Share and Potential Dilution
  June 30,2009
    
    
    2008Stock options
    
    
    9,661,326
    
    
    
    9,567,891Warrants issued in relation to debt and equity arrangements
    
    
    10,260,246
    
    
    
    10,434,804Total anti-dilutive securities excluded from EPS calculation
    
    
    19,921,572
    
    
    
    20,002,695
  10




---



##### Table of Contents



9. Commitments and contingencies
 Leases
  Payments Due by PeriodTotal
    
    
    1 Year
    
    
    Years 2 & 3
    
    
    Beyond 3 YearsOperating leases
    
    $
    5,277,000
    
    
    $
    1,165,000
    
    
    $
    2,116,000
    
    
    $
    1,996,000Debt (long-term and short-term)
    
    
    419,000
    
    
    
    148,000
    
    
    
    271,000
    
    
    
    Total
    
    $
    5,696,000
    
    
    $
    1,313,000
    
    
    $
    2,387,000
    
    
    $
    1,996,000
   Claims and Proceedings
  
 ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 NOTE ON FORWARD-LOOKING STATEMENTS AND RISK FACTORS
 Management Discussion
and Analysis
  Overview
  11




---



##### Table of Contents



Strategic Alternatives Review
  Critical Accounting Policies and Estimates
  Summary of Significant Accounting
Policies Critical Accounting Policies and
Estimates
 Results of Operations
 Second Quarter 2009 Summary of Operations
 Financial
 
    
    Revenue for the quarter ended June 30, 2009, was $7,371,000 compared with $6,958,000 for
the same period in 2008 representing a 6% increase.
    
    Gross profit for the quarter ended June 30, 2009, was $5,003,000 or 68% of revenues
compared with $4,416,000 or 63% of revenues for the comparable period in 2008.
 Email Encryption
 e-Prescribing
 
    
    Net loss for the quarter ended June 30, 2009 was $1,925,000 compared with a net loss of
$1,350,000 in 2008. Included in the loss for the quarter ended June 30, 2009 was
approximately $600,000 of non-recurring severance costs and non-recurring expenses related
to the Companys strategic alternatives review of its e-Prescribing business segment.
    
    Ending cash and cash equivalents were $12,494,000 on June 30, 2009 compared with
$13,245,000 on December 31, 2008.
 Operations
 
    
    For the Email Encryption service, new first year orders (NFYO or NFYOs) for the
quarter ended June 30, 2009, were $1,650,000 and customer contract renewals were 86% on a
contract value basis. The renewal rate of 86% was lower than our historical rate of 93% to
95%. The factors driving the non-renewal generally fell into two categories: impact of the
economy or competition. The economy has in many cases resulted in reduced IT budgets
forcing customers either to cut back on the number of users or services they purchased or,
in one instance that we know of, decide to do without an email encryption solution
altogether. In other cases, competition was the primary driver which manifested itself
either through lower prices or a desire to purchase bundled solutions that included
anti-spam and anti-virus services.
 12




---



##### Table of Contents




    
    We deployed approximately 325 new e-Prescribing devices to prescribers and reached
approximately 2.5 million electronic prescriptions transacted in the three-month period
ended June 30, 2009 (19% higher than the same period in 2008).
 Revenues
  3-month Variance
    
    
    
    
    
    
    
    
    
    
    6-month VarianceThree Months Ended, June 30,
    
    
    2009 vs. 2008
    
    
    Six Months Ended, June 30,
    
    
    2009 vs. 20082009
    
    
    2008
    
    
    $
    
    
    %
    
    
    2009
    
    
    2008
    
    
    $
    
    
    %Email Encryption
    
    $
    6,379,000
    
    
    $
    5,667,000
    
    
    $
    712,000
    
    
    
    13
    %
    
    $
    12,621,000
    
    
    $
    10,956,000
    
    
    $
    1,665,000
    
    
    
    15
    %e-Prescribing
    
    
    992,000
    
    
    
    1,291,000
    
    
    
    (299,000
    )
    
    
    (23
    %)
    
    
    2,006,000
    
    
    
    3,201,000
    
    
    
    (1,195,000
    )
    
    
    (37
    %)Total revenues
    
    $
    7,371,000
    
    
    $
    6,958,000
    
    
    $
    413,000
    
    
    
    6
    %
    
    $
    14,627,000
    
    
    $
    14,157,000
    
    
    $
    470,000
    
    
    
    3
    %
  Revenue Indicators  Backlog, Orders and Deployments
 Company-wide backlog 
  Email Encryption Orders 
 e-Prescribing 
   13




---



##### Table of Contents



Cost of Revenues
  3-month Variance
    
    
    
    
    
    
    
    
    
    
    6-month VarianceThree Months Ended, June 30,
    
    
    2009 vs. 2008
    
    
    Six Months Ended, June 30,
    
    
    2009 vs. 20082009
    
    
    2008
    
    
    $
    
    
    %
    
    
    2009
    
    
    2008
    
    
    $
    
    
    %Email Encryption
    
    $
    1,088,000
    
    
    $
    1,059,000
    
    
    $
    29,000
    
    
    
    3
    %
    
    $
    2,101,000
    
    
    $
    2,109,000
    
    
    $
    (8,000
    )
    
    
    0
    %e-Prescribing
    
    
    1,280,000
    
    
    
    1,483,000
    
    
    
    (203,000
    )
    
    
    (14
    %)
    
    
    2,738,000
    
    
    
    3,013,000
    
    
    
    (275,000
    )
    
    
    (9
    %)Total cost of revenues
    
    $
    2,368,000
    
    
    $
    2,542,000
    
    
    $
    (174,000
    )
    
    
    (7
    %)
    
    $
    4,839,000
    
    
    $
    5,122,000
    
    
    $
    (283,000
    )
    
    
    (6
    %)
  14




---



##### Table of Contents



Email Encryption 
 e-Prescribing 
 Research and Development Expenses
  3-month Variance
    
    
    
    
    
    
    
    
    
    6-month VarianceThree Months Ended, June 30,
    
    2009 vs. 2008
    
    Six Months Ended, June 30,
    
    2009 vs. 20082009
    
    2008
    
    $
    
    %
    
    2009
    
    2008
    
    $
    
    %Research and development
    
    $
    1,747,000
    
    
    $
    1,381,000
    
    
    $
    366,000
    
    
    
    27
    %
    
    $
    3,478,000
    
    
    $
    2,926,000
    
    
    $
    552,000
    
    
    
    19
    %
     Selling, General and Administrative Expenses
  3-month Variance
    
    
    
    
    
    
    
    
    
    6-month VarianceThree Months Ended, June 30,
    
    2009 vs. 2008
    
    Six Months Ended, June 30,
    
    2009 vs. 20082009
    
    2008
    
    $
    
    %
    
    2009
    
    2008
    
    $
    
    %Selling, general and administrative
    
    $
    5,228,000
    
    
    $
    4,607,000
    
    
    $
    621,000
    
    
    
    13
    %
    
    $
    9,872,000
    
    
    $
    9,424,000
    
    
    $
    448,000
    
    
    
    5
    %
 15




---



##### Table of Contents



Other Income, net
  Provision for Income Taxes
      Net Loss
  16




---



##### Table of Contents



Liquidity and Capital Resources
 Overview
     Impact of Current Economic Environment
  Sources and Uses of Cash Summary
 Six Months Ended June 30,2009
    
    2008Net cash (used in) provided by operations
    
    $
    (239,000
    )
    
    $
    1,143,000Net cash (used in) provided by investing activities
    
    $
    (512,000
    )
    
    $
    1,190,000Net cash provided by financing activities
    
    $
    
    
    
    $
    150,000
 17




---



##### Table of Contents



Liquidity Summary
  Options and Warrants of ZixCorp Common Stock
  Summary of Outstanding Options and WarrantsVestedTotal Value
    
    
    (included in
    
    
    Total Value ofExercise Price Range
    
    Outstanding
    
    
    Outstanding
    
    
    Outstanding)
    
    
    Vested$1.11 - $1.99
    
    
    7,519,819
    
    
    $
    11,487,000
    
    
    
    6,685,051
    
    
    $
    10,322,000$2.00 - $3.49
    
    
    4,961,352
    
    
    
    14,837,000
    
    
    
    4,915,911
    
    
    
    14,705,000$3.50 - $4.99
    
    
    4,065,934
    
    
    
    18,114,000
    
    
    
    3,282,279
    
    
    
    14,376,000$5.00 - $5.99
    
    
    549,260
    
    
    
    2,791,000
    
    
    
    549,260
    
    
    
    2,791,000$6.00 - $8.99
    
    
    908,483
    
    
    
    5,786,000
    
    
    
    908,483
    
    
    
    5,786,000$9.00 - $19.99
    
    
    890,381
    
    
    
    9,727,000
    
    
    
    890,381
    
    
    
    9,727,000$20.00 - $57.60
    
    
    1,026,343
    
    
    
    56,222,000
    
    
    
    1,026,343
    
    
    
    56,222,000Total
    
    
    19,921,572
    
    
    $
    118,964,000
    
    
    
    18,257,708
    
    
    $
    113,929,000
 Off-Balance Sheet Arrangements
  18




---



##### Table of Contents



Contractual Obligations, Contingent Liabilities and Commitments
  Payments Due by PeriodTotal
    
    
    1 Year
    
    
    Years 2 & 3
    
    
    Beyond 3 YearsOperating leases
    
    $
    5,277,000
    
    
    $
    1,165,000
    
    
    $
    2,116,000
    
    
    $
    1,996,000Debt (long-term and short-term)
    
    
    419,000
    
    
    
    148,000
    
    
    
    271,000
    
    
    
    Total
    
    $
    5,696,000
    
    
    $
    1,313,000
    
    
    $
    2,387,000
    
    
    $
    1,996,000
   
 ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
  
 ITEM 4. CONTROLS AND PROCEDURES
  Changes in Internal Controls over Financial Reporting
  
 PART II  OTHER INFORMATION
 
 ITEM 1. Legal Proceedings
  
 ITEM 1A. Risk Factors
 We could be affected by government regulation
 We could be affected by government regulation
 19




---



##### Table of Contents



ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
  20




---



##### Table of Contents



ITEM 3. DEFAULTS UPON SENIOR SECURITIES
  
 ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
  
 ITEM 5. OTHER INFORMATION
  21




---



##### Table of Contents



ITEM 6. EXHIBITS
 a. Exhibits
  Exhibit No.
    
    Description of Exhibits3.1
    
    Restated Articles of Incorporation of Zix Corporation, as
filed with the Texas Secretary of State on November 10, 2005.
Filed as Exhibit 3.1 to Zix Corporations Annual Report on
Form 10-K for the year ended December 31, 2005, and
incorporated herein by reference.3.2
    
    Amended and Restated Bylaws of Zix Corporation, dated February
4, 2009. Filed as Exhibit 3.1 to Zix Corporations Current
Report on Form 8-K, dated February 10, 2009, and incorporated
herein by reference.10.1
    
    Lease, dated April 9, 2009, between ZixCorp Canada, Inc. and
Zix Corporation and Elk Property Management Limited (relating
to Zix Corporations Ottawa, Canada offices). Filed as
Exhibit 10.1 to Zix Corporations Quarterly Report on Form
10-Q for the quarterly period ended March 31, 2009, and
incorporated herein by reference.31.1*
    
    Certification of Richard D. Spurr, President and Chief
Executive Officer of the Company, pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002.31.2*
    
    Certification of Susan K. Conner, Chief Financial Officer of
the Company, pursuant to Section 302 of the Sarbanes-Oxley Act
of 2002.32.1**
    
    Certification of Richard D. Spurr, President and Chief
Executive Officer of the Company, and Susan K. Conner, Chief
Financial Officer of the Company, pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002.
 
 *
    
    Filed herewith.**
    
    Furnished herewith. 22




---



##### Table of Contents



SIGNATURES
  ZIX CORPORATIONDate: August 5, 2009
    By:
    /s/ Susan K. ConnerSusan K. ConnerChief Financial Officer 23